Metabolism and Interspecies Variation of IMMH-010, a Programmed Cell Death Ligand 1 Inhibitor Prodrug
IMMH-010 is an ester prodrug of YPD-29B, a potent programmed cell death ligand 1 (PD-L1) inhibitor. The metabolism of IMMH-010 was investigated and compared in various species. Four metabolites of IMMH-010 were identified, and the major metabolite was the parent compound, YPD-29B, which was mainly c...
Saved in:
Main Authors: | Yuchen Wang (Author), Xiao Liu (Author), Xiaowen Zou (Author), Shuting Wang (Author), Lijun Luo (Author), Yuke Liu (Author), Kai Dong (Author), Xiaoqing Yao (Author), Yan Li (Author), Xiaoguang Chen (Author), Li Sheng (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Simultaneous Determination of a Novel PD-L1 Inhibitor, IMMH-010, and Its Active Metabolite, YPD-29B, in Rat Biological Matrices by Polarity-Switching Liquid Chromatography-Tandem Mass Spectrometry: Application to ADME Studies
by: Jianwei Jiang, et al.
Published: (2021) -
Interspecies Variation of In Vitro Stability and Metabolic Diversity of YZG-331, a Promising Sedative-Hypnotic Compound
by: Zhihao Liu, et al.
Published: (2017) -
The nucleoside antiviral prodrug remdesivir in treating COVID-19 and beyond with interspecies significance
by: Daisy Yan, et al.
Published: (2021) -
A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models
by: Jing Jin, et al.
Published: (2020) -
Sphingosine-1-Phosphate Receptor Subtype 1 (S1P1) Modulator IMMH001 Regulates Adjuvant- and Collagen-Induced Arthritis
by: Jing Jin, et al.
Published: (2019)